Covid-19 treatment: Dr Reddy's partners with Fujifilm, GRA for favipiravir

Dr Reddy's will herewith establish a setup for manufacturing drugs of the same quality as Avigan, and utilize GRA's global sales network to supply the manufactured drugs swiftly and in a stable manner

Dr Reddy's Laboratories on Wednesday announced partnership with Tokyo-based Fujifilm Corporation and Dubai-based Global Response Aid for the development, manufacture and sales of Avigan Tablets (favipiravir), a potential treatment of Covid-19.

Under the tripartite agreement, Fujifilm grants Dr Reddy's the exclusive rights of manufacturing.

Also it grants both Dr Reddy's and GRA the rights to develop, sell and distribute Avigan in all countries other than Japan, China and Russia, a press release from the Indian drug maker said.

The company would have exclusive rights for development, selling and distribution of Avigan in India.

Further, Fujifilm would receive an upfront undisclosed